• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Richard D. Gelber, PhD

Publications

  • Oakman C, Francis PA, Crown J, Quinaux E, Buyse M, De Azambuja E, Margeli Vila M, Andersson M, Nordenskjöld B, Jakesz R, Thürlimann B, Gutiérrez J, Harvey V, Punzalan L, Dell'orto P, Larsimont D, Steinberg I, Gelber RD, Piccart-Gebhart M, Viale G, Di Leo A.Overall survival benefit for sequential doxorubicin-docetaxel compared with concurrent doxorubicin and docetaxel in node-positive breast cancer--8-year results of the Breast International Group 02-98 phase III trial.Ann Oncol. 2013 May;24(5):1203-11.
    23293111
  • Metzger-Filho O, Procter M, de Azambuja E, Leyland-Jones B, Gelber RD, Dowsett M, Loi S, Saini KS, Cameron D, Untch M, Smith I, Gianni L, Baselga J, Jackisch C, Bell R, Sotiriou C, Viale G, Piccart-Gebhart M.Magnitude of Trastuzumab Benefit in Patients With HER2-Positive, Invasive Lobular Breast Carcinoma: Results From the HERA Trial.J Clin Oncol. 2013 Apr 15.
    23589556
  • Galimberti V, Cole BF, Zurrida S, Viale G, Luini A, Veronesi P, Baratella P, Chifu C, Sargenti M, Intra M, Gentilini O, Mastropasqua MG, Mazzarol G, Massarut S, Garbay JR, Zgajnar J, Galatius H, Recalcati A, Littlejohn D, Bamert M, Colleoni M, Price KN, Regan MM, Goldhirsch A, Coates AS, Gelber RD, Veronesi U, .Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial.Lancet Oncol. 2013 Apr;14(4):297-305.
    23491275
  • Crivellari D, Gray KP, Dellapasqua S, Puglisi F, Ribi K, Price KN, Láng I, Gianni L, Spazzapan S, Pinotti G, Lüthi JM, Gelber RD, Regan MM, Colleoni M, Castiglione-Gertsch M, Maibach R, Rabaglio M, Coates AS, Goldhirsch A.Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a "standard chemotherapy regimen": The CASA randomized trial.Breast. 2013 Apr;22(2):130-7.
    23453899
  • Pestalozzi BC, Holmes E, de Azambuja E, Metzger-Filho O, Hogge L, Scullion M, Láng I, Wardley A, Lichinitser M, Sanchez RI, Müller V, Dodwell D, Gelber RD, Piccart-Gebhart MJ, Cameron D.CNS relapses in patients with HER2-positive early breast cancer who have and have not received adjuvant trastuzumab: a retrospective substudy of the HERA trial (BIG 1-01).Lancet Oncol. 2013 Mar;14(3):244-8.
    23414588
  • Ewertz M, Gray KP, Regan MM, Ejlertsen B, Price KN, Thürlimann B, Bonnefoi H, Forbes JF, Paridaens RJ, Rabaglio M, Gelber RD, Colleoni M, Láng I, Smith IE, Coates AS, Goldhirsch A, Mouridsen HT.Obesity and risk of recurrence or death after adjuvant endocrine therapy with letrozole or tamoxifen in the breast international group 1-98 trial.J Clin Oncol. 2012 Nov 10;30(32):3967-75.
    23045588
  • Coates AS, Millar EK, O'Toole SA, Molloy TJ, Viale G, Goldhirsch A, Regan MM, Gelber RD, Sun Z, Castiglione-Gertsch M, Gusterson B, Musgrove EA, Sutherland RL.Prognostic interaction between expression of p53 and estrogen receptor in patients with node-negative breast cancer: results from IBCSG Trials VIII and IX.Breast Cancer Res. 2012 Nov 5;14(6):R143.
    23127292
  • Goldhirsch A, Gelber RD.Breast cancer: Anastrozole and fulvestrant-combination to unlock efficacy.Nat Rev Clin Oncol. 2012 Sep 4;9(10):556-7.
    22949048
  • Dellapasqua S, Bagnardi V, Regan MM, Rotmensz N, Mastropasqua MG, Viale G, Maiorano E, Price KN, Gelber RD, Castiglione-Gertsch M, Goldhirsch A, Colleoni M.A risk score based on histopathological features predicts higher risk of distant recurrence in premenopausal patients with lymph node-negative endocrine-responsive breast cancer.Breast. 2012 Oct;21(5):621-8.
    22749924
  • Colleoni M, Giobbie-Hurder A, Regan MM, Thürlimann B, Mouridsen H, Mauriac L, Forbes JF, Paridaens R, Láng I, Smith I, Chirgwin J, Pienkowski T, Wardley A, Price KN, Gelber RD, Coates AS, Goldhirsch A.Analyses Adjusting for Selective Crossover Show Improved Overall Survival With Adjuvant Letrozole Compared With Tamoxifen in the BIG 1-98 Study.J Clin Oncol. 2011 Mar 20;29(9):1117-24.
    21321298
  • Gianni L, Dafni U, Gelber RD, Azambuja E, Muehlbauer S, Goldhirsch A, Untch M, Smith I, Baselga J, Jackisch C, Cameron D, Mano M, Pedrini JL, Veronesi A, Mendiola C, Pluzanska A, Semiglazov V, Vrdoljak E, Eckart MJ, Shen Z, Skiadopoulos G, Procter M, Pritchard KI, Piccart-Gebhart MJ, Bell R, .Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial.Lancet Oncol. 2011 Mar;12(3):236-244.
    21354370
  • Karlsson P, Sun Z, Braun D, Price KN, Castiglione-Gertsch M, Rabaglio M, Gelber RD, Crivellari D, Collins J, Murray E, Zaman K, Colleoni M, Gusterson BA, Viale G, Regan MM, Coates AS, Goldhirsch A.Long-term results of International Breast Cancer Study Group Trial VIII: adjuvant chemotherapy plus goserelin compared with either therapy alone for premenopausal patients with node-negative breast cancer.Ann Oncol. 2011 Feb 16.
    21325445
  • Phillips KA, Aldridge J, Ribi K, Sun Z, Thompson A, Harvey V, Thürlimann B, Cardoso F, Pagani O, Coates AS, Goldhirsch A, Price KN, Gelber RD, Bernhard J.Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial.Breast Cancer Res Treat. 2011 Feb;126(1):221-6.
    21046229
  • Lazar AA, Cole BF, Bonetti M, Gelber RD.Evaluation of treatment-effect heterogeneity using biomarkers measured on a continuous scale: subpopulation treatment effect pattern plot.J Clin Oncol. 2010 Oct 10;28(29):4539-44.
    20837942
  • Phillips KA, Ribi K, Sun Z, Stephens A, Thompson A, Harvey V, Thürlimann B, Cardoso F, Pagani O, Coates AS, Goldhirsch A, Price KN, Gelber RD, Bernhard J.Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trial.Breast. 2010 Oct;19(5):388-95.
    20385495
  • Gunnarsdóttir KA, Jensen MB, Zahrieh D, Gelber RD, Knoop A, Bonetti M, Mouridsen H, Ejlertsen B.CEF is superior to CMF for tumours with TOP2A aberrations: a Subpopulation Treatment Effect Pattern Plot (STEPP) analysis on Danish Breast Cancer Cooperative Group Study 89D.Breast Cancer Res Treat. 2010 Aug;123(1):163-9.
    20464479
  • Paridaens RJ, Gelber S, Cole BF, Gelber RD, Thürlimann B, Price KN, Holmberg SB, Crivellari D, Coates AS, Goldhirsch A.Adjuvant!((c)) Online estimation of chemotherapy effectiveness when added to ovarian function suppression plus tamoxifen for premenopausal women with estrogen-receptor-positive breast cancer.Breast Cancer Res Treat. 2010 Aug;123(1):303-10.
    20195744
  • Colleoni M, Cole BF, Viale G, Regan MM, Price KN, Maiorano E, Mastropasqua MG, Crivellari D, Gelber RD, Goldhirsch A, Coates AS, Gusterson BA.Classical cyclophosphamide, methotrexate, and fluorouracil chemotherapy is more effective in triple-negative, node-negative breast cancer: results from two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer.J Clin Oncol. 2010 Jun 20;28(18):2966-73.
    20458051
  • Maiorano E,Regan MM,Viale G,Mastropasqua MG,Colleoni M,Castiglione-Gertsch M,Price KN,Gelber RD,Goldhirsch A,Coates AS.Prognostic and predictive impact of central necrosis and fibrosis in early breast cancer: Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy.Breast Cancer Res Treat. 2010 May;121(1):211-8.
    19280340
  • de Azambuja E, McCaskill-Stevens W, Francis P, Quinaux E, Crown JP, Vicente M, Giuliani R, Nordenskjöld B, Gutiérez J, Andersson M, Vila MM, Jakesz R, Demol J, Dewar J, Santoro A, Lluch A, Olsen S, Gelber RD, Di Leo A, Piccart-Gebhart M.The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial.Breast Cancer Res Treat. 2010 Jan;119(1):145-53.
    19731015
  • Gelber RD, Gelber S, , .Facilitating consensus by examining patterns of treatment effects.Breast. 2009 Oct;18 Suppl 3:S2-8.
    19914537
  • , Mouridsen H, Giobbie-Hurder A, Goldhirsch A, Thürlimann B, Paridaens R, Smith I, Mauriac L, Forbes JF, Price KN, Regan MM, Gelber RD, Coates AS.Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer.N Engl J Med. 2009 Aug 20;361(8):766-76.
    19692688
  • Pagani O,Price KN,Gelber RD,Castiglione-Gertsch M,Holmberg SB,Lindtner J,Thurlimann B,Collins J,Fey MF,Coates AS,Goldhirsch A.Patterns of recurrence of early breast cancer according to estrogen receptor status: a therapeutic target for a quarter of a century.Breast Cancer Res Treat. 2009 Sep;117(2):319-24.
    19137426
  • Grant CS,Ingle JN,Suman VJ,Dumesic DA,Wickerham DL,Gelber RD,Flynn PJ,Weir LM,Intra M,Jones WO,Perez EA,Hartmann LC.Menstrual Cycle and Surgical Treatment of Breast Cancer: Findings From the NCCTG N9431 Study.J Clin Oncol. 2009 Aug 1;27(22):3620-6.
    19487378
  • Desmedt C, Giobbie-Hurder A, Neven P, Paridaens R, Christiaens MR, Smeets A, Lallemand F, Haibe-Kains B, Viale G, Gelber RD, Piccart M, Sotiriou C.The Gene expression Grade Index: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trial.BMC Med Genomics. 2009;2:40.
    19573224
  • Pagani O,Gelber S,Simoncini E,Castiglione-Gertsch M,Price KN,Gelber RD,Holmberg SB,Crivellari D,Collins J,Lindtner J,Thurlimann B,Fey MF,Murray E,Forbes JF,Coates AS,Goldhirsch A.Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93.Breast Cancer Res Treat. 2009 Aug;116(3):491-500.
    18953651
  • Dowsett M,Procter M,McCaskill-Stevens W,de Azambuja E,Dafni U,Rueschoff J,Jordan B,Dolci S,Abramovitz M,Stoss O,Viale G,Gelber RD,Piccart-Gebhart M,Leyland-Jones B.Disease-Free Survival According to Degree of HER2 Amplification for Patients Treated With Adjuvant Chemotherapy With or Without 1 Year of Trastuzumab: The HERA Trial.J Clin Oncol. 2009 Jun 20;27(18):2962-9.
    19364966
  • Giobbie-Hurder A, Price KN, Gelber RD, , .Design, conduct, and analyses of Breast International Group (BIG) 1-98: a randomized, double-blind, phase-III study comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive, early breast cancer.Clin Trials. 2009 Jun;6(3):272-87.
    19528136
  • Colleoni M,Bagnardi V,Rotmensz N,Gelber RD,Viale G,Pruneri G,Veronesi P,Torrisi R,Cardillo A,Montagna E,Campagnoli E,Luini A,Intra M,Galimberti V,Scarano E,Peruzzotti G,Goldhirsch A.Increasing steroid hormone receptors expression defines breast cancer subtypes non responsive to preoperative chemotherapy.Breast Cancer Res Treat. 2009 Jul;116(2):359-69.
    18941889
  • Gelber RD,Aebi S.Endocrine therapy plus zoledronic acid in premenopausal breast cancer.N Engl J Med. 2009 May 28;360(22):2367; author reply 2369-70.
    19484813
  • Sun Z,Goldhirsch A,Price KN,Colleoni M,Ravaioli A,Simoncini E,Campbell I,Gelber RD,Towler M.Bone Quality Test (BQT) scores of fingernails in postmenopausal patients treated with adjuvant letrozole or tamoxifen for early breast cancer.Breast. 2009 Apr;18(2):84-8.
    19243946
  • Bonetti M,Zahrieh D,Cole BF,Gelber RD.A small sample study of the STEPP approach to assessing treatment-covariate interactions in survival data.Stat Med. 2009 Apr 15;28(8):1255-68.
    19170050
  • Thurlimann B, Price KN, Gelber RD, Holmberg SB, Crivellari D, Colleoni M, Collins J, Forbes JF, Castiglione-Gertsch M, Coates AS, Goldhirsch A.Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93.Breast Cancer Res Treat. 2009 Jan;113(1):137-44.
    18259856
  • Gianni L,Gelber S,Ravaioli A,Price KN,Panzini I,Fantini M,Castiglione-Gertsch M,Pagani O,Simoncini E,Gelber RD,Coates AS,Goldhirsch A.Second non-breast primary cancer following adjuvant therapy for early breast cancer: a report from the International Breast Cancer Study Group.Eur J Cancer. 2009 Mar;45(4):561-71.
    19062268
  • Viale G,Giobbie-Hurder A,Regan MM,Coates AS,Mastropasqua MG,Dell'Orto P,Maiorano E,MacGrogan G,Braye SG,Ohlschlegel C,Neven P,Orosz Z,Olszewski WP,Knox F,Thurlimann B,Price KN,Castiglione-Gertsch M,Gelber RD,Gusterson BA,Goldhirsch A.Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole.J Clin Oncol. 2008 Dec 1;26(34):5569-75.
    18981464
  • Anderson JR,Cain KC,Gelber RD.Analysis of survival by tumor response and other comparisons of time-to-event by outcome variables.J Clin Oncol. 2008 Aug 20;26(24):3913-5.
    18711176
  • Bonetti M,Cole BF,Gelber RD.Another STEPP in the right direction.J Clin Oncol. 2008 Aug 1;26(22):3813-4; author reply 3814-5.
    18669475
  • Gruber G, Cole BF, Castiglione-Gertsch M, Holmberg SB, Lindtner J, Golouh R, Collins J, Crivellari D, Thurlimann B, Simoncini E, Fey MF, Gelber RD, Coates AS, Price KN, Goldhirsch A, Viale G, Gusterson BA.Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer.Ann Oncol. 2008 Aug;19(8):1393-401.
    18385202
  • Wapnir IL,Aebi S,Geyer CE,Zahrieh D,Gelber RD,Anderson SJ,Robidoux A,Bernhard J,Maibach R,Castiglione-Gertsch M,Coates AS,Piccart MJ,Clemons MJ,Costantino JP,Wolmark N.A randomized clinical trial of adjuvant chemotherapy for radically resected locoregional relapse of breast cancer: IBCSG 27-02, BIG 1-02, and NSABP B-37.Clin Breast Cancer. 2008 Jun;8(3):287-92.
    18650162
  • Regan MM, Pagani O, Walley B, Torrisi R, Perez EA, Francis P, Fleming GF, Price KN, Thurlimann B, Maibach R, Castiglione-Gertsch M, Coates AS, Goldhirsch A, Gelber RD.Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy?.Ann Oncol. 2008 Jul;19(7):1231-41.
    18325918
  • Pestalozzi BC, Zahrieh D, Mallon E, Gusterson BA, Price KN, Gelber RD, Holmberg SB, Lindtner J, Snyder R, Thurlimann B, Murray E, Viale G, Castiglione-Gertsch M, Coates AS, Goldhirsch A.Distinct Clinical and Prognostic Features of Infiltrating Lobular Carcinoma of the Breast: Combined Results of 15 International Breast Cancer Study Group Clinical Trials.J Clin Oncol. 2008 Jun 20;26(18):3006-14.
    18458044
  • Untch M, Gelber RD, Jackisch C, Procter M, Baselga J, Bell R, Cameron D, Bari M, Smith I, Leyland-Jones B, de Azambuja E, Wermuth P, Khasanov R, Feng-Yi F, Constantin C, Mayordomo JI, Su CH, Yu SY, Lluch A, Senkus-Konefka E, Price C, Haslbauer F, Sahui TS, Srimuninnimit V, Colleoni M, Coates AS, Piccart-Gebhart MJ, Goldhirsch A.Estimating the magnitude of trastuzumab effects within patient subgroups in the HERA trial.Ann Oncol. 2008 Jun;19(6):1090-6.
    18296421
  • Viale G, Regan MM, Maiorano E, Mastropasqua MG, Golouh R, Perin T, Brown RW, Kovacs A, Pillay K, Ohlschlegel C, Braye S, Grigolato P, Rusca T, Gelber RD, Castiglione-Gertsch M, Price KN, Goldhirsch A, Gusterson BA, Coates AS.Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group.J Clin Oncol. 2008 Mar 20;26(9):1404-10.
    18349391
  • Rocca A, Viale G, Gelber RD, Bottiglieri L, Gelber S, Pruneri G, Ghisini R, Balduzzi A, Pietri E, D'Alessandro C, Goldhirsch A, Colleoni M.Pathologic complete remission rate after cisplatin-based primary chemotherapy in breast cancer: correlation with p63 expression.Cancer Chemother Pharmacol. 2008 May;61(6):965-71.
    17639392
  • Crivellari D, Sun Z, Coates AS, Price KN, Thurlimann B, Mouridsen H, Mauriac L, Forbes JF, Paridaens RJ, Castiglione-Gertsch M, Gelber RD, Colleoni M, Lang I, Del Mastro L, Gladieff L, Rabaglio M, Smith IE, Chirgwin JH, Goldhirsch A.Letrozole compared with tamoxifen for elderly patients with endocrine-responsive early breast cancer: the BIG 1-98 trial.J Clin Oncol. 2008 Apr 20;26(12):1972-9.
    18332471
  • Viale G, Regan MM, Mastropasqua MG, Maffini F, Maiorano E, Colleoni M, Price KN, Golouh R, Perin T, Brown RW, Kovacs A, Pillay K, Ohlschlegel C, Gusterson BA, Castiglione-Gertsch M, Gelber RD, Goldhirsch A, Coates AS.Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer.Journal of the National Cancer Institute. 2008 Feb 6;100(3):207-12.
    18230798
  • Francis P, Crown J, Di Leo A, Buyse M, Balil A, Andersson M, Nordenskjold B, Lang I, Jakesz R, Vorobiof D, Gutierrez J, van Hazel G, Dolci S, Jamin S, Bendahmane B, Gelber RD, Goldhirsch A, Castiglione-Gertsch M, Piccart-Gebhart M.Adjuvant chemotherapy with sequential or concurrent anthracycline and docetaxel: Breast International Group 02-98 randomized trial.Journal of the National Cancer Institute. 2008 Jan 16;100(2):121-33.
    18182617
  • Bernhard J, Zahrieh D, Zhang JJ, Martinelli G, Basser R, Hürny C, Forbes JF, Aebi S, Yeo W, Thürlimann B, Green MD, Colleoni M, Gelber RD, Castiglione-Gertsch M, Price KN, Goldhirsch A, Coates AS, .Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer.Br J Cancer. 2008 Jan 15;98(1):25-33.
    18043579
  • Clarke M, Coates AS, Darby SC, Davies C, Gelber RD, Godwin J, Goldhirsch A, Gray R, Peto R, Pritchard KI, Wood WC.Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials.Lancet. 2008 Jan 5;371(9606):29-40. Review.
    18177773
  • Rasmussen BB, Regan MM, Lykkesfeldt AE, Dell'Orto P, Del Curto B, Henriksen KL, Mastropasqua MG, Price KN, Mery E, Lacroix-Triki M, Braye S, Altermatt HJ, Gelber RD, Castiglione-Gertsch M, Goldhirsch A, Gusterson BA, Thurlimann B, Coates AS, Viale G.Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial.Lancet Oncol. 2008 Jan;9(1):23-8.
    18083065
  • Mouridsen H, Keshaviah A, Coates AS, Rabaglio M, Castiglione-Gertsch M, Sun Z, Thurlimann B, Mauriac L, Forbes JF, Paridaens R, Gelber RD, Colleoni M, Smith I, Price KN, Goldhirsch A.Cardiovascular adverse events during adjuvant endocrine therapy for early breast cancer using letrozole or tamoxifen: safety analysis of BIG 1-98 trial.J Clin Oncol. 2007 Dec 20;25(36):5715-22.
    17998546
  • Suter TM, Procter M, van Veldhuisen DJ, Muscholl M, Bergh J, Carlomagno C, Perren T, Passalacqua R, Bighin C, Klijn JG, Ageev FT, Hitre E, Groetz J, Iwata H, Knap M, Gnant M, Muehlbauer S, Spence A, Gelber RD, Piccart-Gebhart MJ.Trastuzumab-Associated Cardiac Adverse Effects in the Herceptin Adjuvant Trial.J Clin Oncol. 2007 Sep 1;25(25):3859-65.
    17646669
  • Regan MM, Gelber RD.Using clinical trial data to tailor adjuvant treatments for individual patients.Breast. 2007 Dec;16 Suppl 2:S98-104.
    17719227
  • Viale G, Regan MM, Maiorano E, Mastropasqua MG, Dell'Orto P, Rasmussen BB, Raffoul J, Neven P, Orosz Z, Braye S, Ohlschlegel C, Thurlimann B, Gelber RD, Castiglione-Gertsch M, Price KN, Goldhirsch A, Gusterson BA, Coates AS.Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1-98.J Clin Oncol. 2007 Sep 1;25(25):3846-52.
    17679725
  • Partridge A, Gelber S, Gelber RD, Castiglione-Gertsch M, Goldhirsch A, Winer E.Age of menopause among women who remain premenopausal following treatment for early breast cancer: Long-term results from International Breast Cancer Study Group Trials V and VI.Eur J Cancer. 2007 Jul;43(11):1646-53.
    17512721
  • Hudis CA, Barlow WE, Costantino JP, Gray RJ, Pritchard KI, Chapman JA, Sparano JA, Hunsberger S, Enos RA, Gelber RD, Zujewski JA.Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system.J Clin Oncol. 2007 May 20;25(15):2127-32.
    17513820
  • Jordan VC, Gelber RD.Problems with the progesterone receptor in practice?.J Clin Oncol. 2007 May 20;25(15):1957-9.
    17452674
  • Colleoni M, Gelber S, Simoncini E, Pagani O, Gelber RD, Price KN, Castiglione-Gertsch M, Coates AS, Goldhirsch A.Effects of a treatment gap during adjuvant chemotherapy in node-positive breast cancer: results of International Breast Cancer Study Group (IBCSG) Trials 13-93 and 14-93.Ann Oncol. 2007 Jul;18(7):1177-84.
    17429101
  • Karlsson P, Cole BF, Price KN, Coates AS, Castiglione-Gertsch M, Gusterson BA, Murray E, Lindtner J, Collins JP, Holmberg SB, Fey MF, Thrlimann B, Crivellari D, Forbes JF, Gelber RD, Goldhirsch A, Wallgren A.The role of the number of uninvolved lymph nodes in predicting locoregional recurrence in breast cancer.J Clin Oncol. 2007 May 20;25(15):2019-26.
    17420511
  • Mauriac L, Keshaviah A, Debled M, Mouridsen H, Forbes J, Thrlimann B, Paridaens R, Monnier A, Lng I, Wardley A, Nogaret JM, Gelber R, Castiglione-Gertsch M, Price K, Coates A, Smith I, Viale G, Rabaglio M, Zabaznyi N, Goldhirsch A.Predictors of early relapse in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial.Ann Oncol. 2007 May;18(5):859-67.
    17301074
  • Keshaviah A, Dellapasqua S, Rotmensz N, Lindtner J, Crivellari D, Collins J, Colleoni M, Thrlimann B, Mendiola C, Aebi S, Price KN, Pagani O, Simoncini E, Castiglione Gertsch M, Gelber RD, Coates AS, Goldhirsch A.CA15-3 and alkaline phosphatase as predictors for breast cancer recurrence: a combined analysis of seven International Breast Cancer Study Group trials.Ann Oncol. 2007 Apr;18(4):701-8.
    17237474
  • Smith I, Procter M, Gelber RD, Guillaume S, Feyereislova A, Dowsett M, Goldhirsch A, Untch M, Mariani G, Baselga J, Kaufmann M, Cameron D, Bell R, Bergh J, Coleman R, Wardley A, Harbeck N, Lopez RI, Mallmann P, Gelmon K, Wilcken N, Wist E, Sanchez Rovira P, Piccart-Gebhart MJ.2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial.Lancet. 2007 Jan 6;369(9555):29-36.
    17208639
  • Coates AS, Keshaviah A, Thrlimann B, Mouridsen H, Mauriac L, Forbes JF, Paridaens R, Castiglione-Gertsch M, Gelber RD, Colleoni M, Lng I, Del Mastro L, Smith I, Chirgwin J, Nogaret JM, Pienkowski T, Wardley A, Jakobsen EH, Price KN, Goldhirsch A.Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98.J Clin Oncol. 2007 Feb 10;25(5):486-92.
    17200148
  • Bernhard J, Zahrieh D, Castiglione-Gertsch M, Hrny C, Gelber RD, Forbes JF, Murray E, Collins J, Aebi S, Thrlimann B, Price KN, Goldhirsch A, Coates AS,.Adjuvant chemotherapy followed by goserelin compared with either modality alone: the impact on amenorrhea, hot flashes, and quality of life in premenopausal patients--the International Breast Cancer Study Group Trial VIII.J Clin Oncol. 2007 Jan 20;25(3):263-70.
    17159194
  • Regan MM, Viale G, Mastropasqua MG, Maiorano E, Golouh R, Carbone A, Brown B, Suurkla M, Langman G, Mazzucchelli L, Braye S, Grigolato P, Gelber RD, Castiglione-Gertsch M, Price KN, Coates AS, Goldhirsch A, Gusterson B,.Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.Journal of the National Cancer Institute. 2006 Nov 1;98(21):1571-81.
    17077359
  • Goldhirsch A, Coates AS, Gelber RD, Glick JH, Thrlimann B, Senn HJ,.First--select the target: better choice of adjuvant treatments for breast cancer patients.Ann Oncol. 2006 Dec;17(12):1772-6.
    17071934
  • Regan MM, Viale G, Mastropasqua MG, Maiorano E, Golouh R, Carbone A, Brown B, Suurkla M, Langman G, Mazzucchelli L, Braye S, Grigolato P, Gelber RD, Castiglione-Gertsch M, Price KN, Coates AS, Goldhirsch A, Gusterson B.the IBCSG. Re-evaluating adjuvant breast cancer trials according to hormone receptors determined by immunohistochemistry versus extraction assays.J Natl Cancer Inst. In Press;In Press.
  • Pestalozzi BC, Zahrieh D, Price KN, Holmberg SB, Lindtner J, Collins J, Crivellari D, Fey MF, Murray E, Pagani O, Simoncini E, Castiglione-Gertsch M, Gelber RD, Coates AS, Goldhirsch A,.Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG).Ann Oncol. 2006 Jun;17(6):935-44.
    16603601
  • Colleoni M, Gelber S, Goldhirsch A, Aebi S, Castiglione-Gertsch M, Price KN, Coates AS, Gelber RD,.Tamoxifen after adjuvant chemotherapy for premenopausal women with lymph node-positive breast cancer: International Breast Cancer Study Group Trial 13-93.J Clin Oncol. 2006 Mar 20;24(9):1332-41.
    16505417
  • Wong JS, Kaelin CM, Troyan SL, Gadd MA, Gelman R, Lester SC, Schnitt SJ, Sgroi DC, Silver BJ, Harris JR, Smith BL.Prospective study of wide excision alone for ductal carcinoma in situ of the breast.J Clin Oncol. 2006 Mar 1;24(7):1031-6.
    16461781
  • Fitzmaurice GM, Lipsitz SR, Ibrahim JG, Gelber R, Lipshultz S.Estimation in regression models for longitudinal binary data with outcome-dependent follow-up.Biostatistics. 2006 Jul;7(3):469-85.
    16428260
  • Basser RL, O'Neill A, Martinelli G, Green MD, Peccatori F, Cinieri S, Coates AS, Gelber RD, Aebi S, Castiglione-Gertsch M, Viale G, Price KN, Goldhirsch A,.Multicycle dose-intensive chemotherapy for women with high-risk primary breast cancer: results of International Breast Cancer Study Group Trial 15-95.J Clin Oncol. 2006 Jan 20;24(3):370-8.
    16421418
  • Regan MM, Viale G, Mastropasqua MG, Maiorano E, Golouh R, Carbone A, Brown B, Suurkla M, Langman G, Mazzucchelli L, Braye S, Grigolato P, Gelber RD, Castiglione-Gertsch M, Price KN, Coates AS, Goldhirsch A, Gusterson B, for the IBCSG.Re-evaluating adjuvant breast cancer trials according to hormone receptors determined by immunohistochemistry versus extraction assays.Journal of the National Cancer Institute.;98(21):1571-1581.
  • Thrlimann B, Keshaviah A, Coates AS, Mouridsen H, Mauriac L, Forbes JF, Paridaens R, Castiglione-Gertsch M, Gelber RD, Rabaglio M, Smith I, Wardley A, Wardly A, Price KN, Goldhirsch A,.A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer.N Engl J Med. 2005 Dec 29;353(26):2747-57.
    16382061
  • Gianni L, Panzini I, Li S, Gelber RD, Collins J, Holmberg SB, Crivellari D, Castiglione-Gertsch M, Goldhirsch A, Coates AS, Ravaioli A,.Ocular toxicity during adjuvant chemoendocrine therapy for early breast cancer: results from International Breast Cancer Study Group trials.Cancer. 2006 Feb 1;106(3):505-13.
    16369994
  • Rudenstam CM, Zahrieh D, Forbes JF, Crivellari D, Holmberg SB, Rey P, Dent D, Campbell I, Bernhard J, Price KN, Castiglione-Gertsch M, Goldhirsch A, Gelber RD, Coates AS,.Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93.J Clin Oncol. 2006 Jan 20;24(3):337-44.
    16344321
  • Goldhirsch A, Gelber RD, Coates AS.What are the long-term effects of chemotherapy and hormonal therapy for early breast cancer?.Nat Clin Pract Oncol. 2005 Sep;2(9):440-1.
    16265010
  • Regan MM, Gelber RD.Predicting response to systemic treatments: learning from the past to plan for the future.Breast. 2005 Dec;14(6):582-93.
    16199162
  • Goldhirsch A, Glick JH, Gelber RD, Coates AS, Thrlimann B, Senn HJ,.Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005.Ann Oncol. 2005 Oct;16(10):1569-83.
    16148022
  • Cole BF, Bonetti M, Zaslavsky AM, Gelber RD.A multistate Markov chain model for longitudinal, categorical quality-of-life data subject to non-ignorable missingness.Stat Med. 2005 Aug 15;24(15):2317-34.
    15977292
  • Lipshultz SE, Lipsitz SR, Sallan SE, Dalton VM, Mone SM, Gelber RD, Colan SD.Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia.J Clin Oncol. 2005 Apr 20;23(12):2629-36.
    15837978
  • Winer EP, Hudis C, Burstein HJ, Wolff AC, Pritchard KI, Ingle JN, Chlebowski RT, Gelber R, Edge SB, Gralow J, Cobleigh MA, Mamounas EP, Goldstein LJ, Whelan TJ, Powles TJ, Bryant J, Perkins C, Perotti J, Braun S, Langer AS, Browman GP, Somerfield MR.American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004.J Clin Oncol. 2005 Jan 20;23(3):619-29.
    15545664
  • Crivellari D, Price K, Gelber RD, Castiglione-Gertsch M, Rudenstam CM, Lindtner J, Fey MF, Senn HJ, Coates AS, Collins J, Goldhirsch A,.Adjuvant endocrine therapy compared with no systemic therapy for elderly women with early breast cancer: 21-year results of International Breast Cancer Study Group Trial IV.J Clin Oncol. 2003 Dec 15;21(24):4517-23.
    14673038
  • Gelber RD, Bonetti M, Castiglione-Gertsch M, Coates AS, Goldhirsch A,.Tailoring adjuvant treatments for the individual breast cancer patient.Breast. 2003 Dec;12(6):558-68.
    14659135
  • Colleoni M, Zarieh D, Gelber RD, Viale G, Luini A, Veronesi P, Intra M, Galimberti V, Renne G, Goldhirsch A.Preoperative systemic treatment: prediction of responsiveness.Breast. 2003 Dec;12(6):538-42.
    14659132
  • Goldberg JM, Silverman LB, Levy DE, Dalton VK, Gelber RD, Lehmann L, Cohen HJ, Sallan SE, Asselin BL.Childhood T-cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience.J Clin Oncol. 2003 Oct 1;21(19):3616-22.
    14512392
  • Dalton VK, Rue M, Silverman LB, Gelber RD, Asselin BL, Barr RD, Clavell LA, Hurwitz CA, Moghrabi A, Samson Y, Schorin M, Tarbell NJ, Sallan SE, Cohen LE.Height and weight in children treated for acute lymphoblastic leukemia: relationship to CNS treatment.J Clin Oncol. 2003 Aug 1;21(15):2953-60.
    12885815
  • Goldhirsch A, Wood WC, Gelber RD, Coates AS, Thrlimann B, Senn HJ.Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer.J Clin Oncol. 2003 Sep 1;21(17):3357-65.
    12847142
  • Mirochnick M, Dorenbaum A, Blanchard S, Cunningham CK, Gelber RD, Mofenson L, Culnane M, Sullivan JL.Predose infant nevirapine concentration with the two-dose intrapartum neonatal nevirapine regimen: association with timing of maternal intrapartum nevirapine dose.J Acquir Immune Defic Syndr. 2003 Jun 1;33(2):153-6.
    12794547
  • Winer EP, Hudis C, Burstein HJ, Bryant J, Chlebowski RT, Ingle JN, Edge SB, Mamounas EP, Gelber R, Gralow J, Goldstein LJ, Pritchard KI, Braun S, Cobleigh MA, Langer AS, Perotti J, Powles TJ, Whelan TJ, Browman GP.American Society of Clinical Oncology technology assessment working group update: use of aromatase inhibitors in the adjuvant setting.J Clin Oncol. 2003 Jul 1;21(13):2597-9.
    12732612
  • Wallgren A, Bonetti M, Gelber RD, Goldhirsch A, Castiglione-Gertsch M, Holmberg SB, Lindtner J, Thrlimann B, Fey M, Werner ID, Forbes JF, Price K, Coates AS, Collins J,.Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VII.J Clin Oncol. 2003 Apr 1;21(7):1205-13.
    12663706
  • Trihia H, Murray S, Price K, Gelber RD, Golouh R, Goldhirsch A, Coates AS, Collins J, Castiglione-Gertsch M, Gusterson BA,.Ki-67 expression in breast carcinoma: its association with grading systems, clinical parameters, and other prognostic factors--a surrogate marker?.Cancer. 2003 Mar 1;97(5):1321-31.
    12599241
  • Goldhirsch A, Colleoni M, Gelber RD.Endocrine therapy of breast cancer.Ann Oncol. 2002;13 Suppl 4:61-8.
    12401668
  • Lipsitz SR, Fitzmaurice GM, Ibrahim JG, Gelber R, Lipshultz S.Parameter estimation in longitudinal studies with outcome-dependent follow-up.Biometrics. 2002 Sep;58(3):621-30.
    12229997
  • Cunningham CK, Chaix ML, Rekacewicz C, Britto P, Rouzioux C, Gelber RD, Dorenbaum A, Delfraissy JF, Bazin B, Mofenson L, Sullivan JL.Development of resistance mutations in women receiving standard antiretroviral therapy who received intrapartum nevirapine to prevent perinatal human immunodeficiency virus type 1 transmission: a substudy of pediatric AIDS clinical trials group protocol 3.J Infect Dis. 2002 Jul 15;186(2):181-8.
    12134253
  • Castiglione-Gertsch M, Price KN, Goldhirsch A, Coates AS, Colleoni M, Nasi ML, Bernhar J, Zahrieh D, Bonetti M, Gelber RD.Endocrine responsiveness and tailoring adjuvant therapy for postmenopausal lymph node-negative breast cancer: a randomized trial.J Natl Cancer Inst. 2002 Jul 17;94(14):1054-1065.
  • Dorenbaum A, Cunningham CK, Gelber RD, Culnane M, Mofenson L, Britto P, Rekacewicz C, Newell ML, Delfraissy JF, Cunningham-Schrader B, Mirochnick M, Sullivan JL,.Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial.JAMA. 2002 Jul 10;288(2):189-98.
    12095383
  • Colleoni M, Litman HJ, Castiglione-Gertsch M, Sauerbrei W, Gelber RD, Bonetti M, Coates AS, Schumacher M, Bastert G, Rudenstam CM, Schmoor C, Lindtner J, Collins J, Thrlimann B, Holmberg SB, Crivellari D, Beyerle C, Neumann RL, Goldhirsch A, ,.Duration of adjuvant chemotherapy for breast cancer: a joint analysis of two randomised trials investigating three versus six courses of CMF.Br J Cancer. 2002 Jun 5;86(11):1705-14.
    12087454
  • Earle CC, Neumann PJ, Gelber RD, Weinstein MC, Weeks JC.Impact of referral patterns on the use of chemotherapy for lung cancer.J Clin Oncol. 2002 Apr 1;20(7):1786-92.
    11919235
  • Lipshultz SE, Giantris AL, Lipsitz SR, Kimball Dalton V, Asselin BL, Barr RD, Clavell LA, Hurwitz CA, Moghrabi A, Samson Y, Schorin MA, Gelber RD, Sallan SE, Colan SD.Doxorubicin administration by continuous infusion is not cardioprotective: the Dana-Farber 91-01 Acute Lymphoblastic Leukemia protocol.J Clin Oncol. 2002 Mar 15;20(6):1677-82.
    11896119
  • Weeks JC, Nelson H, Gelber S, Sargent D, Schroeder G,.Short-term quality-of-life outcomes following laparoscopic-assisted colectomy vs open colectomy for colon cancer: a randomized trial.JAMA. 2002 Jan 16;287(3):321-8.
    11790211
  • LeClerc JM, Billett AL, Gelber RD, Dalton V, Tarbell N, Lipton JM, Barr R, Clavell LA, Asselin B, Hurwitz C, Schorin M, Lipshultz SE, Declerck L, Silverman LB, Cohen HJ, Sallan SE.Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber ALL Consortium Protocol 87-01.J Clin Oncol. 2002 Jan 1;20(1):237-46.
    11773175
  • Goldhirsch A, Gelber RD, Yothers G, Gray RJ, Green S, Bryant J, Gelber S, Castiglione-Gertsch M, Coates AS.Adjuvant therapy for very young women with breast cancer: need for tailored treatments.J Natl Cancer Inst Monogr. 2001(30):44-51.
    11773291
  • Colleoni M, Gelber S, Coates AS, Castiglione-Gertsch M, Gelber RD, Price K, Rudenstam CM, Lindtner J, Collins J, Thrlimann B, Holmberg SB, Cortes-Funes H, Simoncini E, Murray E, Fey M, Goldhirsch A,.Influence of endocrine-related factors on response to perioperative chemotherapy for patients with node-negative breast cancer.J Clin Oncol. 2001 Nov 1;19(21):4141-9.
    11689582
  • Cole BF, Gelber RD, Gelber S, Coates AS, Goldhirsch A.Polychemotherapy for early breast cancer: an overview of the randomised clinical trials with quality-adjusted survival analysis.Lancet. 2001 Jul 28;358(9278):277-86.
    11498214
  • Waber DP, Shapiro BL, Carpentieri SC, Gelber RD, Zou G, Dufresne A, Romero I, Tarbell NJ, Silverman LB, Sallan SE.Excellent therapeutic efficacy and minimal late neurotoxicity in children treated with 18 grays of cranial radiation therapy for high-risk acute lymphoblastic leukemia: a 7-year follow-up study of the Dana-Farber Cancer Institute Consortium Protocol 87-01.Cancer. 2001 Jul 1;92(1):15-22.
    11443604
  • Fine JP, Gelber RD.Joint regression analysis of survival and quality-adjusted survival.Biometrics. 2001 Jun;57(2):376-82.
    11414559
  • Gelber S, Coates AS, Goldhirsch A, Castiglione-Gertsch M, Marini G, Lindtner J, Edelmann DZ, Gudgeon A, Harvey V, Gelber RD,.Effect of pregnancy on overall survival after the diagnosis of early-stage breast cancer.J Clin Oncol. 2001 Mar 15;19(6):1671-5.
    11250996
  • Silverman LB, Gelber RD, Dalton VK, Asselin BL, Barr RD, Clavell LA, Hurwitz CA, Moghrabi A, Samson Y, Schorin MA, Arkin S, Declerck L, Cohen HJ, Sallan SE.Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01.Blood. 2001 Mar 1;97(5):1211-8.
    11222362
  • Schwartz CL, Thompson EB, Gelber RD, Young ML, Chilton D, Cohen HJ, Sallan SE.Improved response with higher corticosteroid dose in children with acute lymphoblastic leukemia.J Clin Oncol. 2001 Feb 15;19(4):1040-6.
    11181667
  • Earle CC, Tsai JS, Gelber RD, Weinstein MC, Neumann PJ, Weeks JC.Effectiveness of chemotherapy for advanced lung cancer in the elderly: instrumental variable and propensity analysis.J Clin Oncol. 2001 Feb 15;19(4):1064-70.
    11181670
  • Colleoni M, O'Neill A, Goldhirsch A, Gelber RD, Bonetti M, Thrlimann B, Price KN, Castiglione-Gertsch M, Coates AS, Lindtner J, Collins J, Senn HJ, Cavalli F, Forbes J, Gudgeon A, Simoncini E, Cortes-Funes H, Veronesi A, Fey M, Rudenstam CM.Identifying breast cancer patients at high risk for bone metastases.J Clin Oncol. 2000 Dec 1;18(23):3925-35.
    11099322
  • Coates AS, Hrny C, Peterson HF, Bernhard J, Castiglione-Gertsch M, Gelber RD, Goldhirsch A.Quality-of-life scores predict outcome in metastatic but not early breast cancer. International Breast Cancer Study Group.J Clin Oncol. 2000 Nov 15;18(22):3768-74.
    11078489
  • Nakamura S, Gelber RD, Blattner S, Sallan SE, Chanock SJ.Long-term follow-up and infectious complications of therapy for acute lymphoblastic leukemia in children.International Journal of Pediatric Hematology/Oncology. 2000 Nov;6(5):321-330.
  • Bonetti M, Gelber RD.A graphical method to assess treatment-covariate interactions using the Cox model on subsets of the data.Stat Med. 2000 Oct 15;19(19):2595-609.
    10986536
  • Aebi S, Gelber S, Castiglione-Gertsch M, Gelber RD, Collins J, Thrlimann B, Rudenstam CM, Lindtner J, Crivellari D, Cortes-Funes H, Simoncini E, Werner ID, Coates AS, Goldhirsch A.Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?.Lancet. 2000 May 27;355(9218):1869-74.
    10866443
  • Earle CC, Venditti LN, Neumann PJ, Gelber RD, Weinstein MC, Potosky AL, Weeks JC.Who gets chemotherapy for metastatic lung cancer?.Chest. 2000 May;117(5):1239-46.
    10807806
  • Crivellari D, Bonetti M, Castiglione-Gertsch M, Gelber RD, Rudenstam CM, Thrlimann B, Price KN, Coates AS, Hrny C, Bernhard J, Lindtner J, Collins J, Senn HJ, Cavalli F, Forbes J, Gudgeon A, Simoncini E, Cortes-Funes H, Veronesi A, Fey M, Goldhirsch A.Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VII.J Clin Oncol. 2000 Apr;18(7):1412-22.
    10735888
  • Colleoni M, Bonetti M, Coates AS, Castiglione-Gertsch M, Gelber RD, Price K, Rudenstam CM, Lindtner J, Collins J, Thrlimann B, Holmberg S, Veronesi A, Marini G, Goldhirsch A.Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors. The International Breast Cancer Study Group.J Clin Oncol. 2000 Feb;18(3):584-90.
    10653873
  • Cote RJ, Peterson HF, Chaiwun B, Gelber RD, Goldhirsch A, Castiglione-Gertsch M, Gusterson B, Neville AM.Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study Group.Lancet. 1999 Sep 11;354(9182):896-900.
    10489948
  • Goldhirsch A, Glick JH, Gelber RD, Senn HJ.Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer.J Natl Cancer Inst. 1998 Nov 4;90(21):1601-8.
    9811309
  • Kimball Dalton VM, Gelber RD, Li F, Donnelly MJ, Tarbell NJ, Sallan SE.Second malignancies in patients treated for childhood acute lymphoblastic leukemia.J Clin Oncol. 1998 Aug;16(8):2848-53.
    9704738
  • Glasziou PP, Cole BF, Gelber RD, Hilden J, Simes RJ.Quality adjusted survival analysis with repeated quality of life measures.Stat Med. 1998 Jun 15;17(11):1215-29.
    9670411
  • Cole BF, Solal-Cligny P, Gelber RD, Lepage E, Gisselbrecht C, Reyes F, Sebban C, Sugano D, Tendler C, Goldhirsch A.Quality-of-life-adjusted survival analysis of interferon alfa-2b treatment for advanced follicular lymphoma: an aid to clinical decision making.J Clin Oncol. 1998 Jul;16(7):2339-44.
    9667248
  • Goldhirsch A, Coates AS, Colleoni M, Castiglione-Gertsch M, Gelber RD.Adjuvant chemoendocrine therapy in postmenopausal breast cancer: cyclophosphamide, methotrexate, and fluorouracil dose and schedule may make a difference. International Breast Cancer Study Group.J Clin Oncol. 1998 Apr;16(4):1358-62.
    9552037
  • Gelber RD, Goldhirsch A, Cole BF, Wieand HS, Schroeder G, Krook JE.A quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis of adjuvant radiation therapy and chemotherapy for resectable rectal cancer.J Natl Cancer Inst. 1996 Aug 7;88(15):1039-45.
    8683634
  • Hrny C, Bernhard J, Coates AS, Castiglione-Gertsch M, Peterson HF, Gelber RD, Forbes JF, Rudenstam CM, Simoncini E, Crivellari D, Goldhirsch A, Senn HJ.Impact of adjuvant therapy on quality of life in women with node-positive operable breast cancer. International Breast Cancer Study Group.Lancet. 1996 May 11;347(9011):1279-84.
    8622502
  • Gelber RD, Cole BF, Goldhirsch A, Rose C, Fisher B, Osborne CK, Boccardo F, Gray R, Gordon NH, Bengtsson NO, Sevelda P.Adjuvant chemotherapy plus tamoxifen compared with tamoxifen alone for postmenopausal breast cancer: meta-analysis of quality-adjusted survival.Lancet. 1996 Apr 20;347(9008):1066-71.
    8602056
  • Goldhirsch A, Wood WC, Senn HJ, Glick JH, Gelber RD.Meeting highlights: international consensus panel on the treatment of primary breast cancer.J Natl Cancer Inst. 1995 Oct 4;87(19):1441-5.
    7674331
  • Cole BF, Gelber RD, Goldhirsch A.A quality-adjusted survival meta-analysis of adjuvant chemotherapy for premenopausal breast cancer. International Breast Cancer Study Group.Stat Med. 1995 Aug 30;14(16):1771-84.
    7481209
  • Spector SA, Gelber RD, McGrath N, Wara D, Barzilai A, Abrams E, Bryson YJ, Dankner WM, Livingston RA, Connor EM.A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection. Pediatric AIDS Clinical Trials Group.N Engl J Med. 1994 Nov 3;331(18):1181-7.
    7935655
  • Gelber RD, Goldhirsch A, Cole BF.Parametric extrapolation of survival estimates with applications to quality of life evaluation of treatments. International Breast Cancer Study Group.Control Clin Trials. 1993 Dec;14(6):485-99.
    8119064
  • Cole BF, Gelber RD, Goldhirsch A.Cox regression models for quality adjusted survival analysis.Stat Med. 1993 May 30;12(10):975-87.
    8337554
  • Gelber RD, Goldhirsch A, Coates AS.Adjuvant therapy for breast cancer: understanding the overview. International Breast Cancer Study Group.J Clin Oncol. 1993 Mar;11(3):580-5.
    8445434
  • Gelber RD, Goldhirsch A.Meta-analysis: the fashion of summing-up evidence. Part I. Rationale and conduct.Ann Oncol. 1991 Jul;2(7):461-8.
    1911452
  • Gelber RD, Goldhirsch A, Cavalli F.Quality-of-life-adjusted evaluation of adjuvant therapies for operable breast cancer. The International Breast Cancer Study Group.Ann Intern Med. 1991 Apr 15;114(8):621-8.
    2003707